NAT11 antibody

GeneTex

NAT11 antibody

9

WB: 1 - 2 microg/mL. IHC-P: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

NAA40

N-alpha-acetyltransferase 40, NatD catalytic subunit

hNatD; N(alpha)-acetyltransferase 40, NatD catalytic subunit, homolog; N-acetyltransferase 11 (GCN5-related, putative); N-alpha acetyl transferase 40; N-alpha-acetyltransferase 40; N-alpha-acetyltransferase D; NAT11; NatD; natD catalytic subunit; PATT1; protein acetyltransferase 1

Rabbit

IgG

N-alpha-acetyltransferase 40

N-terminal acetylation is one of the most common protein modifications in eukaryotes, occurring on approximately 57% and 84% on yeast and human proteins respectively. There are several N-terminal acetylating enzyme complexes (NatA - NatE). Unlike the other complexes, NatD is composed of a single protein, NAT11, and has recently been described to acetylate the Serine N-termini of histones H2A and H4 in yeast. The role these modifications play is unknown; yeast that do not express NAT11 grow at normal rates and have no observable phenotypes. The role of the human homolog is likewise unknown.

Human, Mouse

-20°C or -80°C,2°C to 8°C

12352203